Rheumatology — Find Specialists & Top Hospitals Worldwide | MyMedicPlus

Rheumatology is the medical specialty dedicated to the diagnosis and treatment of musculoskeletal diseases and systemic autoimmune and inflammatory conditions. Rheumatic diseases affect the joints, muscles, bones, and connective tissues, and in their systemic forms can involve virtually any organ in the body — including the kidneys, lungs, heart, skin, eyes, and nervous system.

Rheumatologists are internal medicine specialists with advanced training in clinical immunology and musculoskeletal medicine. Many conditions managed by rheumatologists arise from dysregulation of the immune system, in which the body's own immune cells and antibodies attack healthy tissues. The specialty is therefore deeply intertwined with immunology, and rheumatologists are at the forefront of applying biological therapies that target specific immune pathways to achieve disease remission.

The field encompasses several overlapping domains. Inflammatory arthritis specialists manage conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using disease-modifying antirheumatic drugs (DMARDs) and biologic therapies. Connective tissue disease specialists treat systemic lupus erythematosus (SLE), Sjogren syndrome, scleroderma, and inflammatory myopathies. Vasculitis specialists manage the complex group of conditions causing blood vessel wall inflammation. Crystal arthropathy specialists address gout and pseudogout. Osteoporosis and metabolic bone disease specialists manage fracture risk assessment and prevention. Paediatric rheumatologists treat juvenile idiopathic arthritis and systemic autoimmune diseases in children.

Early diagnosis and treatment of inflammatory arthritis is now established as essential — a 'window of opportunity' in the first three months of disease offers the greatest potential to achieve and sustain remission and prevent irreversible joint damage.

Rheumatologists manage a wide spectrum of autoimmune, inflammatory, and musculoskeletal conditions:

• Rheumatoid arthritis (RA): Chronic autoimmune inflammatory arthritis characterised by symmetrical small joint synovitis, morning stiffness exceeding one hour, and systemic features; treated with methotrexate and biologic DMARDs including TNF inhibitors, IL-6 inhibitors, and JAK inhibitors.
• Psoriatic arthritis: Inflammatory arthritis occurring in up to 30% of patients with psoriasis, affecting peripheral joints, axial spine, entheses, and dactylitic digits, managed with DMARDs and biologics.
• Ankylosing spondylitis (axial spondyloarthritis): Inflammatory arthritis predominantly affecting the sacroiliac joints and spine, causing progressive stiffness and pain, managed with NSAIDs, biologics (TNF inhibitors, IL-17 inhibitors), and physiotherapy.
• Systemic lupus erythematosus (SLE): Multi-system autoimmune disease causing malar rash, photosensitivity, arthritis, nephritis, serositis, and haematological abnormalities; characterised by positive ANA and anti-dsDNA antibodies.
• Sjogren syndrome: Autoimmune exocrinopathy causing dry eyes and dry mouth; may be primary or secondary to other connective tissue diseases, associated with extraglandular features including neuropathy and lymphoma risk.
• Systemic sclerosis (scleroderma): Autoimmune fibrotic disease causing skin thickening, Raynaud phenomenon, interstitial lung disease, pulmonary hypertension, and gastrointestinal dysmotility.
• Polymyalgia rheumatica: Inflammatory condition in adults over 50 causing shoulder and pelvic girdle aching and stiffness with elevated ESR and CRP, rapidly responsive to low-dose corticosteroids.
• Gout: Crystal arthropathy caused by monosodium urate crystal deposition in joints, causing acute attacks of severe arthritis, managed with colchicine, NSAIDs, and urate-lowering therapy (allopurinol, febuxostat).
• Giant cell arteritis (GCA): Large-vessel vasculitis in older adults causing temporal headache, jaw claudication, and risk of irreversible vision loss, requiring high-dose corticosteroids and tocilizumab.
• ANCA-associated vasculitis: Small-vessel vasculitis including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis, affecting the kidneys, lungs, sinuses, and skin, requiring rituximab or cyclophosphamide induction.

Rheumatologists perform a range of diagnostic and therapeutic procedures central to inflammatory disease management:

• Joint aspiration (arthrocentesis) and injection: Aspirating fluid from swollen joints (knee, shoulder, wrist) for cell count, crystal examination, and culture; and injecting corticosteroids or hyaluronic acid for therapeutic effect.
• Musculoskeletal ultrasound: Point-of-care imaging to detect joint synovitis, tendon sheath effusions, enthesitis, and crystal deposits with greater sensitivity than clinical examination alone; used for guiding joint injections.
• Synovial biopsy: Ultrasound- or arthroscope-guided biopsy of the synovial membrane for tissue diagnosis in seronegative or atypical inflammatory arthritis.
• Bone density assessment (DEXA scan): Dual-energy X-ray absorptiometry to measure bone mineral density at the hip and spine, guiding osteoporosis treatment decisions in patients on long-term corticosteroids.
• Autoantibody panel interpretation: Including ANA (antinuclear antibody), anti-dsDNA, anti-Sm, anti-Ro/La, anti-CCP (anti-cyclic citrullinated peptide), rheumatoid factor (RF), ANCA, anti-Scl-70, and complement levels to aid differential diagnosis.
• Biologic therapy initiation and monitoring: Prescribing and monitoring subcutaneous or intravenous biologic DMARDs including TNF inhibitors (adalimumab, etanercept, infliximab), IL-6 inhibitors (tocilizumab, sarilumab), IL-17 inhibitors (secukinumab, ixekizumab), IL-23 inhibitors, and JAK inhibitors (tofacitinib, baricitinib, upadacitinib).
• Infusion therapy: Administering intravenous biologics (rituximab, infliximab, belimumab, cyclophosphamide) in infusion suites with monitoring for infusion reactions.
• Temporal artery biopsy: Surgical biopsy of the superficial temporal artery to confirm the diagnosis of giant cell arteritis histologically.

Rheumatology referral is indicated in several important clinical situations:

• Inflammatory arthritis features: Morning joint stiffness lasting more than 45 minutes, symmetrical swelling of small joints of the hands and feet, warm and tender joints, or joint swelling that does not improve with standard analgesia warrants urgent rheumatology referral — ideally within three months of symptom onset to access the treatment window.
• Positive autoantibody tests: A positive ANA with high titre (1:160 or above), positive anti-CCP, positive ANCA, or other specific autoantibodies detected on blood tests require rheumatology interpretation in the context of clinical symptoms.
• Suspected lupus or connective tissue disease: Unexplained multi-system involvement including rash, arthritis, nephritis, pleuritis, or haematological abnormalities in a young woman should prompt urgent rheumatology referral.
• Refractory gout: Patients with more than two gout attacks per year, tophi, or gout not controlled despite adequate doses of allopurinol require rheumatology assessment for optimisation of urate-lowering therapy or alternative agents.
• Suspected vasculitis: New-onset sinusitis with epistaxis, haemoptysis, purpuric rash, renal impairment with haematuria, or constitutional symptoms with elevated inflammatory markers may indicate systemic vasculitis requiring urgent evaluation.
• Abnormal inflammatory markers: Persistently elevated CRP, ESR, or ferritin without clear cause, particularly with joint or systemic symptoms, warrants rheumatological assessment.

Rheumatologists undergo comprehensive specialised training spanning clinical medicine and clinical immunology. In the United States, the training pathway begins with a four-year medical degree (MD or DO), followed by a three-year internal medicine residency. This is followed by a two-year rheumatology fellowship at an ACGME-accredited programme.

During fellowship, rheumatology trainees develop expertise in the clinical examination of joints and soft tissues, interpretation of musculoskeletal imaging (plain X-rays, MRI, ultrasound), autoantibody testing and immunological laboratory interpretation, and the management of the full spectrum of rheumatic diseases in both outpatient and inpatient settings. Fellows perform joint aspiration and injection techniques under supervision and develop familiarity with all classes of DMARD and biologic therapy.

Many rheumatology fellows also participate in research activities, as the specialty has a strong academic tradition with rapidly evolving therapeutic advances. Fellowship in paediatric rheumatology is available for those wishing to treat children with rheumatic diseases.

Board certification is awarded by the American Board of Internal Medicine (ABIM) upon passing the rheumatology certifying examination. In the UK, rheumatologists hold MRCP and complete a CCT in rheumatology. Ongoing participation in clinical trials, continuing medical education, and subspecialty meetings is expected given the rapid pace of drug development — new biologic targets and small molecule therapies continue to transform outcomes in inflammatory arthritis and lupus.

Ask your GP or internist for a rheumatology referral if you have persistent joint swelling, morning stiffness exceeding one hour, unexplained systemic symptoms, or a positive autoantibody test. Early referral for rheumatoid arthritis is critical — treating within the first three months of symptom onset significantly reduces the likelihood of permanent joint damage and disability.

At your first rheumatology appointment, your doctor will conduct a detailed joint examination, review blood tests including inflammatory markers (CRP, ESR, full blood count), autoantibody testing (ANA, RF, anti-CCP), and baseline organ function tests (renal and liver function). Bring any prior blood tests, imaging, and a list of all current medications. Ask your rheumatologist about the target for treatment (remission or low disease activity), the monitoring schedule for your medications (particularly methotrexate, which requires regular blood tests), and what signs of disease flare or medication side effects to watch for between appointments.